C4 Therapeutics (CCCC) EBITDA Margin Growth (3y) (2022 - 2026)
C4 Therapeutics (CCCC) EBITDA Margin Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
C4 Therapeutics |
520.69 Mn |
285.02 Mn |
- |
46,638.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
46,638.00 |
| Dec 31, 2025 |
107,156.00 |
| Sep 30, 2025 |
20,004.00 |
| Jun 30, 2025 |
-19,885.00 |
| Mar 31, 2025 |
8,688.00 |
| Dec 31, 2024 |
-59,451.00 |
| Sep 30, 2024 |
13,666.00 |
| Jun 30, 2024 |
8,254.00 |
| Mar 31, 2024 |
-65,772.00 |
| Dec 31, 2023 |
-77,818.00 |
| Sep 30, 2023 |
2,204.00 |
| Jun 30, 2023 |
-121,066.00 |
| Mar 31, 2023 |
-70,613.00 |
| Dec 31, 2022 |
-113,629.00 |
| Sep 30, 2022 |
-29,734.00 |
